Resources Contact Us Home
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Image Number 17 for United States Patent #8129185.

Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4.sup.+CD25.sup.+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

  Recently Added Patents
Contact lens material
Pear tree named `PremP109`
Aqueous composition with agents to inhibit water evaporation
Motor assembly
Circuit board having semiconductor chip embedded therein
Motor and disk drive apparatus
Magnifying glass
  Randomly Featured Patents
Method of constructing bedding tags
Methods and system for determining angles of sight between two devices
Modular avionics system of an aircraft
Metal complex reaction product of furfurylamine and a metal carbonyl
Pet emergency disaster shelter and method
Noise suppression inductor
Air pump or similar article
Processes for producing 2-Halo-nicotinic acid derivatives and precursors thereto
Method of removing ion implanted photoresist
Planar modular interconnect system